282 related articles for article (PubMed ID: 34692490)
1. The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.
Qi J; Zhang J; Ge X; Wang X; Xu L; Liu N; Zhao L; Wang P
Front Oncol; 2021; 11():713014. PubMed ID: 34692490
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
3. Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer.
Chen C; Yang H; Cai D; Xiang L; Fang W; Wang R
Transl Lung Cancer Res; 2021 Feb; 10(2):866-877. PubMed ID: 33718028
[TBL] [Abstract][Full Text] [Related]
4. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
5. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
[TBL] [Abstract][Full Text] [Related]
6. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
7. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Zheng C; Ye S; Liu W; Diao M; Li L
Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
[TBL] [Abstract][Full Text] [Related]
9. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
Yang N; Han X; Yu J; Shu W; Qiu F; Han J
J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score.
Zhang Z; Wang D; Zhang J; Ruan Y; Zhao L; Yang L; Liu Z; Yang L; Lou C
Cancer Immunol Immunother; 2023 Nov; 72(11):3635-3649. PubMed ID: 37668711
[TBL] [Abstract][Full Text] [Related]
13. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
14. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer.
Hua X; Duan F; Zhai W; Song C; Jiang C; Wang L; Huang J; Lin H; Yuan Z
J Inflamm Res; 2022; 15():381-394. PubMed ID: 35079223
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer.
Zhang X; Ren H; Tian J; Yang C; Luo H
Heliyon; 2024 Jan; 10(1):e23830. PubMed ID: 38192754
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
17. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
[No Abstract] [Full Text] [Related]
18. Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.
Wang F; Chen L; Wang Z; Xu Q; Huang H; Wang H; Li X; Yu M; Chen J; Lin F; Chen Z; Zhang X; Yang Q; Mou Y; Guo C
Cancer Cell Int; 2022 Oct; 22(1):320. PubMed ID: 36242047
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.
Wang X; Teng F; Kong L; Yu J
Onco Targets Ther; 2016; 9():5761-5770. PubMed ID: 27703374
[TBL] [Abstract][Full Text] [Related]
20. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
